MONDAY, Oct. 6, 2025 — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the...
Vous n'êtes pas connecté
MONDAY, Oct. 6, 2025 — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure, a new study says. Sotatercept reduced patient’s risk...
MONDAY, Oct. 6, 2025 — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the...
Sotatercept drug may foster lung health in severe pulmonary hypertension patients, controlling pathological spread and hospitalization risk.
Sotatercept drug may foster lung health in severe pulmonary hypertension patients, controlling pathological spread and hospitalization risk.
THURSDAY, Oct. 9, 2025 -- The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical...
A new study has shown that a drug called sotatercept could make a big difference in treating a serious lung disease known as pulmonary arterial...
WEDNESDAY, Oct. 15, 2025 — The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a...
WEDNESDAY, Oct. 15, 2025 — The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a...
High blood pressure, also known as hypertension, is a serious health issue that affects more than one in three Australian adults. If it’s not...
A large new study from the University of Leeds has found that people with long-term inflammatory diseases who take oral steroids are more likely to...
AZN's baxdrostat hit the main goal in the phase III Bax24 study, showing significant blood pressure reductions in patients with resistant...